Development Pipeline

Our strategic roadmap to revolutionize CRISPR therapy design through AI-powered innovation

Key Metrics

>1M
Datasets Processed
>50
Enterprise Trials Simulated
99.7%
Prediction Accuracy
24/7
Platform Availability

Prototype

Completed

MVP on Streamlit

Streamlit demo deployed
Basic CRISPR design interface
Mock data integration

Pre-clinical Validation

Current

In silico trial simulation

In silico ID of top 5 gRNAs
Off-target prediction models
Efficacy simulation framework

Beta Launch

Upcoming

Closed researcher access

Researcher beta program
API documentation release
Feedback integration system

Commercial Rollout

Future

API SaaS & partnerships

Full platform launch
Enterprise partnerships
Global market expansion

Development Progress

Q1 2024
Prototype Complete
Q2 2024
Validation Phase
Q3 2024
Beta Launch
Q4 2024
Commercial Rollout

Be part of the next generation of gene therapy innovation